| Pharmaceutical active ingredients: |
| Mitoguazone Dihydrochloride Monohydrate |
| Available forms, composition and doses of Methyl-Gag: |
| Injectable; Injection; Mitoguazone Dihydrochloride Monohydrate 100 mg |
| Methyl-Gag medical category: |
| Human:Cytotoxic chemotherapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01XX16 - Mitoguazone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| OrganonDakota Pharma |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Meno-Implant | Estradiol | Organon |
| Menstrogen | Estradiol Benzoate; Progesterone | Organon |
| Mercilon | Desogestrel; Ethinyl Estradiol | Organon; Akzo Nobel; Essex; Firma Chun Cheong; Merck; Neopharm, Israel; Pharmaco, New Zealand; Schering-Plough; United Drug; Zuellig Pharma |
| Mercilon 28 | Desogestrel; Ethinyl Estradiol | Organon; Akzo Nobel; Essex; Firma Chun Cheong; Merck; Neopharm, Israel; Pharmaco, New Zealand; Schering-Plough; United Drug; Zuellig Pharma |
| Mersilon | Desogestrel; Ethinyl Estradiol | Organon |
| Methylprednisolone | Methylprednisolone Sodium Succinate | Organon |
| Metrigen Fuerte | Estradiol Benzoate; Progesterone | Organon |
| Metronour | Metronidazole | Organon; Nourypharma |
| Microdiol | Desogestrel; Ethinyl Estradiol | Organon; Akzo Nobel; Neopharm, Israel |
| Minilyn | Ethinyl Estradiol; Lynestrenol | Organon |